Acinar arterial changes with chronic lung disease of prematurity in the surfactant era

Donald W Thibeault1, William E Truog, Ikechukwu I Ekekezie

  • 1Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri 64108, USA. dthibeault@cmh.edu

Pediatric Pulmonology
|November 18, 2003
PubMed

Insights

Infants with severe chronic lung disease (CLD) show arterial wall changes suggesting pulmonary hypertension (PH). These findings indicate PH is likely in severe CLD cases and may guide oxygen therapy decisions.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Pulmonary Medicine

Background:

  • Echocardiographic studies suggest pulmonary hypertension (PH) may worsen chronic lung disease (CLD) severity in infants.
  • Understanding arterial wall remodeling in CLD is crucial for managing potential PH.

Purpose of the Study:

  • To investigate acinar arterial wall characteristics in infants with varying degrees of CLD.
  • To determine if arterial wall changes correlate with CLD severity and suggest PH.

Main Methods:

  • Analysis of lung tissue from control infants and infants with mild, moderate, and severe CLD, including those with prolonged rupture of fetal membranes (PROM) and persistent pulmonary hypertension (PPHN).
  • Vessels were stained for elastic tissue and smooth muscle actin.
  • Assessment of percent arterial wall thickness (%AWT), smooth muscle, and elastic laminae extent at different airway levels.

Main Results:

  • Infants with mild CLD showed less %AWT at alveolar ductal and saccular levels compared to controls and severe CLD, suggesting delayed postnatal thinning or remodeling.
  • Severe CLD infants exhibited higher circumferential actin and increased elastic laminae extent compared to controls and mild CLD.
  • Arterial wall changes were more pronounced in PROM and PPHN infants than in severe CLD infants.

Conclusions:

  • Pulmonary hypertension (PH) is a significant concern in infants with severe chronic lung disease (CLD) before discharge at 36 weeks.
  • Assessing CLD severity and utilizing echocardiography can inform subsequent oxygen therapy strategies.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...